Development of a reactive oxygen species (ROS)-responsive nanoplatform for targeted oral cancer therapy
Qing Li(Ministry of Agriculture and Rural Affairs), Xin Xu(Shandong University), Xing Chen(Harbin Medical University), Yong Wen(Shandong University), Fenghe Zhang(Shandong University), Xiujuan Wei(Shandong University), Vishva Shah(Royal Military College of Canada), Dongdong Tong(Shandong University), Xinru You(Brigham and Women's Hospital), Jun Wu(Nanchang University), Linlin Yin(National Clinical Research Center for Digestive Diseases)
Cited by 53
Related Papers
Myotube Assembly on Nanofibrous and Micropatterned Polymers
|Nano Letters|2006|323
Next-generation unnatural monosaccharides reveal that ESRRB O-GlcNAcylation regulates pluripotency of mouse embryonic stem cells
|Nature Communications|2019|126
FGF15 Activates Hippo Signaling to Suppress Bile Acid Metabolism and Liver Tumorigenesis
|Developmental Cell|2019|109
EGFR tyrosine kinase inhibition induces autophagy in cancer cells
|Cancer Biology & Therapy|2012|100
Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL
|Molecular Cancer Therapeutics|2006|70